The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pharmaceutical company funding and its consequences: A qualitative systematic review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“performed a similar systematic review, of the quantitative analyses of the relationships between research funding and outcomes, methodology, or publication; this review was broader in dates (1966–2002) and in languages of publication [4].”
MethodScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schünemann, H. J., Sprague, S., Mears, D., Schemitsch, E. H., Heels-Ansdell, D., & Devereaux, P. J. (2004) · Europe PMC (PubMed Central) · Cited by 551
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Jørgensen, A. W., Hilden, J., & Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38973.444699.0b · Cited by 444
Bias in published cost effectiveness studies: systematic review
Bell, C. M., Urbach, D. R., Ray, J. G., Bayoumi, A., Rosen, A. B., Greenberg, D., & Neumann, P. J. (2006) · BMJ · doi:10.1136/bmj.38737.607558.80 · Cited by 382
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Ridker, P. M., & Torres, J. (2006) · JAMA · doi:10.1001/jama.295.19.2270 · Cited by 303
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020059007 · Cited by 277
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.2.157 · Cited by 274
Relationship between conflicts of interest and research results
Friedman, L. S., & Richter, E. D. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30617.x · Cited by 258
Quantitative analysis of sponsorship bias in economic studies of antidepressants
Baker, C. B., Johnsrud, M. T., Crismon, M. L., Rosenheck, R. A., & Woods, S. W. (2003) · British Journal of Psychiatry · doi:10.1192/03-2 · Cited by 171
Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development
Fries, J. F., & Krishnan, E. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1170 · Cited by 159
Industry support and correlation to study outcome for papers published in Spine
Shah, R. V., Albert, T. J., Bruegel-Sanchez, V., Vaccaro, A. R., Hilibrand, A. S., & Grauer, J. N. (2005) · Spine · doi:10.1097/01.brs.0000161004.15308.b4 · Cited by 155
Montgomery, J. H., Byerly, M., Carmody, T. J., Li, B., Miller, D. R., Varghese, F. P., & Holland, R. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.09.002 · Cited by 117
Miners, A. H., Garau, M., Fidan, D., & Fischer, A. J. (2004) · BMJ · doi:10.1136/bmj.38285.482350.82 · Cited by 89
Extent and impact of industry sponsorship conflicts of interest in dermatology research
Perlis, C., Harwood, M., & Perlis, R. H. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.01.020 · Cited by 79
Moncrieff, J. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.2.161 · Cited by 74
Finucane, T. E., & Boult, C. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.029 · Cited by 69
Relationship between drug company funding and outcomes of clinical psychiatric research
KELLY, R. E., Cohen, L. J., Semple, R. J., Bialer, P. A., Lau, A., BODENHEIMER, A., NEUSTADTER, E., Barenboim, A., & GALYNKER, I. I. (2006) · Psychological Medicine · doi:10.1017/s0033291706008567 · Cited by 64
Bias from industry trial funding? A framework, a suggested approach, and a negative result
Barden, J., Derry, S., McQuay, H. J., & Moore, A. R. (2006) · Pain · doi:10.1016/j.pain.2005.12.011 · Cited by 62
Procyshyn, R. M., Chau, A. M. T., Fortin, P. M., & Jenkins, W. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900905 · Cited by 57
Getting it right: industry sponsorship and medical research.
Baird, P. A. (2003) · Europe PMC (PubMed Central) · Cited by 55
Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
Brown, A., Kraft, D., Schmitz, S. M., Sharpless, V., Martin, C., Shah, R., & Shaheen, N. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.019 · Cited by 53
Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
LISS, H. P. (2006) · PubMed · Cited by 31
Beutels, P. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.001 · Cited by 28
Money, Method and Medical Research
Brown, J. R. (2004) · Episteme · doi:10.3366/epi.2004.1.1.49 · Cited by 15
A meta‐analysis comparing trials of antimuscarinic medications funded by industry or not
Tulikangas, P. K., Ayers, A., & O’SULLIVAN, D. M. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06254.x · Cited by 11
Cited by
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Cohen, J. F., Korevaar, D. A., Altman, D. G., Bruns, D. E., Gatsonis, C. A., Hooft, L., Irwig, L., Levine, D., Reitsma, J. B., de Vet, H. C. W., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012799 · Cited by 2,570
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
Fanelli, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005738 · Cited by 1,911
“This would support growing fears that the large financial interests that often drive medical research are severely biasing it [50], [51], [52].”
BackgroundMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Metadata
- Authors
- Sismondo, S.
- Venue
- Contemporary Clinical Trials
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 29
- Issue
- 2
- Pages
- 109-113
- ISSN
- 1551-7144 (ISSN-L)
- OpenAlex
- W2031244707
- Cited by
- 304
- References
- 30
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.